IL326355A - צורה גבישית של 5-((3r,5s)-3-אמינו-5-טריפלואורומתיל-פיפרידין-1-יל)-כינולין-8-קרבוניטריל - Google Patents
צורה גבישית של 5-((3r,5s)-3-אמינו-5-טריפלואורומתיל-פיפרידין-1-יל)-כינולין-8-קרבוניטרילInfo
- Publication number
- IL326355A IL326355A IL326355A IL32635526A IL326355A IL 326355 A IL326355 A IL 326355A IL 326355 A IL326355 A IL 326355A IL 32635526 A IL32635526 A IL 32635526A IL 326355 A IL326355 A IL 326355A
- Authority
- IL
- Israel
- Prior art keywords
- carbonitrile
- piperidin
- quinoline
- trifluoromethyl
- amino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23190665 | 2023-08-09 | ||
| EP23190662 | 2023-08-09 | ||
| PCT/EP2024/072516 WO2025032197A1 (en) | 2023-08-09 | 2024-08-08 | Crystalline form of 5-((3r,5s)-3-amino-5-trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326355A true IL326355A (he) | 2026-04-01 |
Family
ID=99138879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326355A IL326355A (he) | 2023-08-09 | 2024-08-08 | צורה גבישית של 5-((3r,5s)-3-אמינו-5-טריפלואורומתיל-פיפרידין-1-יל)-כינולין-8-קרבוניטריל |
Country Status (5)
| Country | Link |
|---|---|
| KR (1) | KR20260049624A (he) |
| CN (1) | CN121773097A (he) |
| AU (1) | AU2024323076A1 (he) |
| IL (1) | IL326355A (he) |
| MX (1) | MX2026001456A (he) |
-
2024
- 2024-08-08 IL IL326355A patent/IL326355A/he unknown
- 2024-08-08 KR KR1020267007082A patent/KR20260049624A/ko active Pending
- 2024-08-08 CN CN202480054419.7A patent/CN121773097A/zh active Pending
- 2024-08-08 AU AU2024323076A patent/AU2024323076A1/en active Pending
-
2026
- 2026-02-05 MX MX2026001456A patent/MX2026001456A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2026001456A (es) | 2026-03-02 |
| CN121773097A (zh) | 2026-03-31 |
| KR20260049624A (ko) | 2026-04-14 |
| AU2024323076A1 (en) | 2026-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2011000849A1 (es) | Proceso para la preparacion de compuestos derivados de 2-(benceno/heteroaril)-6-(hidroximetil)-piran-3,4,5-triol utiles como inhibidores de sglt. | |
| IL316075A (he) | צורה גבישית של לניפיברנור | |
| CA2914723C (en) | Processes of making and crystalline forms of a mdm2 inhibitor | |
| IL229232A0 (he) | L–פרולין וחומצה ציטרית קו–גבישים של (2s ,3r, 4r, 5s,6r)–2–(3–((5–(4–פלואורופניל)תיופן–2–איל)מתיל)–4–מתילפניל)–6–(הידרוקסימתיל)טטראהידרו–2h–פיראן–5,4,3 טריאול | |
| WO2018158256A3 (en) | Novel compounds useful as potassium channel openers | |
| SI3908584T1 (sl) | Kristalne oblike 1-(1,2-dimetilpropil)-n-etil-5-metil-n-piridazin-4-il -pirazol-4-karboksamida | |
| GB202102360D0 (en) | Crystalline compound | |
| MX375384B (es) | Formas cristalinas de 1-((2r,4r)-2-(1h-benzo[d]imidazol-2-il)-1-metilpiperidin-4-il)-3-(4-cianofenil)urea maleato. | |
| IL326355A (he) | צורה גבישית של 5-((3r,5s)-3-אמינו-5-טריפלואורומתיל-פיפרידין-1-יל)-כינולין-8-קרבוניטריל | |
| CA3300929A1 (en) | Crystalline form of 5-((3r,5s)-3-amino-5-trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile | |
| IL321171A (he) | צורות גבישיות של 2-אוקסוקווינאזולין | |
| IL325727A (he) | צורה גבישית | |
| PH12021550646A1 (en) | Isoxazole carboxamide compounds and uses thereof | |
| IL326278A (he) | צורה גבישית h1 של 5-((3r,55)-3-אמינו-5-טריפלואורומתיל-פיפרידין-1-יל)-קווינולין-8-קרבוניטריל המיהידרט | |
| IL326346A (he) | צורה גבישית a1 של 5-((55,3r)-3-אמינו-5-טריפלואורומתיל-פיפרידין-1-יל)-כינולין-8-קרבוניטריל הידרוכלוריד | |
| CA3300925A1 (en) | Crystalline form a1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hcl | |
| CA3300783A1 (en) | Crystalline form h1 of 5-((3r,55)-3-amino-5- trifluoromethyl-piperidin-1-yl)-quinoline-8-carbonitrile hemihydrate | |
| WO2011111971A3 (ko) | (r)-3-(3-플루오로-4-(1-메틸-5,6-다이하이드로-1,2,4-트리아진-4(1h)-일)페닐)-5-(치환된 메틸)옥사졸리딘-2-온 유도체의 제조방법 | |
| HK40116601A (en) | Crystalline form of lanifibranor | |
| HK40096047A (en) | Crystalline form of aspacytarabine | |
| HK40082031A (en) | Crystalline form of lnp023 | |
| EP4069674A4 (en) | CRYSTALLINE FORM I OF BUCILLAMIN | |
| LT4615820T (lt) | Kristalinės evenamido formos | |
| CA3296442A1 (en) | Crystalline form | |
| GB202217726D0 (en) | Crystalline compound |